Enhanced Therapeutic Effects Conferred by an Experimental DNA Vaccine Targeting Human Papillomavirus-Induced Tumors

Low-Dose IL-2 for In Vivo Expansion of CD4+ and CD8+ Regulatory T Cells in Nonhuman Primates

(2012) A. Aoyama et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Vaccine-Induced Effector-Memory CD8+ T Cell Responses Predict Therapeutic Efficacy against Tumors

(2012) S. van Duikeren et al.   JOURNAL OF IMMUNOLOGY

Tumor-Targeted Delivery of IL-2 by NKG2D Leads to Accumulation of Antigen-Specific CD8+ T Cells in the Tumor Loci and Enhanced Anti-Tumor Effects

(2012) Tae Heung Kang et al.   PLoS One

Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses

(2012) M. L. Bagarazzi et al.   Science Translational Medicine

Enhanced anti-tumor effect of a gene gun-delivered DNA vaccine encoding the human papillomavirus type 16 oncoproteins genetically fused to the herpes simplex virus glycoprotein D

(2011) M.O. Diniz et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation

(2011) Marcos W. Steinberg et al.   IMMUNOLOGICAL REVIEWS

Purified Herpes Simplex Type 1 Glycoprotein D (gD) Genetically Fused with the Type 16 Human Papillomavirus E7 Oncoprotein Enhances Antigen-Specific CD8+T Cell Responses and Confers Protective Antitumor Immunity

(2011) Bruna F. M. M. Porchia et al.   MOLECULAR PHARMACEUTICS

Immune Responses and Therapeutic Antitumor Effects of an Experimental DNA Vaccine Encoding Human Papillomavirus Type 16 Oncoproteins Genetically Fused to Herpesvirus Glycoprotein D

(2010) M. O. Diniz et al.   Clinical and Vaccine Immunology

Potentiating vaccine immunogenicity by manipulating the HVEM/BTLA pathway and other co-stimulatory and co-inhibitory signals of the immune system

(2010) Marcio O. Lasaro et al.   Human vaccines & immunotherapeutics

Serological response to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia

(2009) Koenraad Van Doorslaer et al.   GYNECOLOGIC ONCOLOGY

HPV vaccination: the beginning of the end of cervical cancer? - A Review

(2009) Ana Paula Lepique et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Involvement of HVEM receptor in activation of nuclear factor κB by herpes simplex virus 1 glycoprotein D

(2008) Maria Teresa Sciortino et al.   CELLULAR MICROBIOLOGY

Induction of Tumor-Specific CD4+ and CD8+ T-Cell Immunity in Cervical Cancer Patients by a Human Papillomavirus Type 16 E6 and E7 Long Peptides Vaccine

(2008) M. J.P. Welters et al.   CLINICAL CANCER RESEARCH

Phase I Immunotherapeutic Trial with Long Peptides Spanning the E6 and E7 Sequences of High-Risk Human Papillomavirus 16 in End-Stage Cervical Cancer Patients Shows Low Toxicity and Robust Immunogenicity

(2008) G. G. Kenter et al.   CLINICAL CANCER RESEARCH

Antigen-specific immunotherapy of cervical and ovarian cancer

(2008) Chien-Fu Hung et al.   IMMUNOLOGICAL REVIEWS

Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses

(2008) Marcio O Lasaro et al.   NATURE MEDICINE

Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting

(2008) Wenjing Li et al.   VACCINE

Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia

(2008) F. Xavier Bosch et al.   VACCINE

Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity

(2008) Balasubramanyam Karanam et al.   VACCINE